Pancreatic cancer patient survival doubled with high dose of common vitamin, study finds

High doses of vitamin C could be a new breakthrough in treating cancer.

The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing the impact of adding high-dose vitamin C to intravenous chemotherapy treatments for pancreatic cancer patients.

The researchers found that administering 75 grams of vitamin C three times a week doubled overall survival rates of patients with late-stage metastatic pancreatic cancer from eight months to 16 months.